IMRX – immuneering corporation - class a (US:NASDAQ)
Stock Stats
News
Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference
Immuneering (NASDAQ:IMRX) was upgraded by analysts at Wall Street Zen
Immuneering (NASDAQ:IMRX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
Immuneering Corporation (IMRX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Form 10-Q Immuneering Corp For: Sep 30
Form 8-K Immuneering Corp For: Nov 12
Form SCHEDULE 13G Immuneering Corp Filed by: Empery Asset Management, LP
Form SCHEDULE 13G Immuneering Corp Filed by: FMR LLC
Form 4 Immuneering Corp For: Oct 03 Filed by: Feinberg Peter
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.